|
Real-time Estimate
Cboe BZX
10:11:20 2026-09-10 am EDT
|
5-day change | 1st Jan Change | ||
| 1.015 USD | -1.46% |
|
-7.27% | -38.92% |
| Market Cap | 260M 224M 211M 192M 360M 24.79B 361M 2.5B 967M 12.63B 978M 957M 40.01B | P/E 2026 * |
-15.3x | P/E 2027 * | -9.88x |
|---|---|---|---|---|---|
| Enterprise Value | 260M 224M 211M 192M 360M 24.79B 361M 2.5B 967M 12.63B 978M 957M 40.01B | EV / Sales 2026 * |
17.1x | EV / Sales 2027 * | 15.5x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
Deutsche Boerse AG
| BT3 | Delayed | |
Börse Stuttgart
| BT3 | Delayed | |
Tradegate
| BT3 | Real-time | |
Boerse Muenchen
| BT3 | Real-time |
Last Transcript : Lineage Cell Therapeutics, Inc.
| 1 day | -5.50% | ||
| 1 week | -7.21% | ||
| Current month | -6.36% | ||
| 1 month | -6.36% | ||
| 3 months | -15.57% | ||
| 6 months | -41.81% | ||
| Current year | -38.32% |
| 1 week | 1.03 | 1.16 | |
| 1 month | 1.03 | 1.18 | |
| Current year | 1 | 1.98 | |
| 1 year | 1 | 2.09 | |
| 3 years | 0.37 | 2.09 | |
| 5 years | 0.37 | 2.71 | |
| 10 years | 0.37 | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 125,000 | 0.0501% | ||
| 7/1/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 7/1/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.50% | -7.21% | -18.90% | -24.26% | 260M | ||
| +0.78% | -6.98% | -2.73% | +11.12% | 46.38B | ||
| +0.17% | -0.74% | +407.28% | +546.58% | 44.51B | ||
| -0.86% | -2.60% | +35.51% | +20.35% | 42.3B | ||
| -0.14% | -2.98% | -0.04% | +82.21% | 39.91B | ||
| 0.00% | -1.72% | +13.42% | +42.33% | 32.79B | ||
| -3.44% | -2.43% | - | - | 17.13B | ||
| -0.78% | -1.13% | +20.74% | +116.26% | 16.36B | ||
| +0.62% | -2.86% | +13.38% | +31.71% | 14.31B | ||
| -0.86% | -4.60% | +76.86% | +39.36% | 13.29B | ||
| Average | -1.22% | -3.32% | +60.61% | +96.18% | 26.72B | |
| Weighted average by Cap. | -0.55% | -3.04% | +85.92% | +132.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.19M 13.07M 12.31M 11.22M 20.99M 1.45B 21.07M 146M 56.39M 737M 57.05M 55.81M 2.33B | 16.83M 14.49M 13.64M 12.43M 23.25M 1.6B 23.35M 162M 62.48M 816M 63.21M 61.84M 2.59B |
| Net income | -22.64M -19.48M -18.34M -16.71M -31.27M -2.15B -31.4M -217M -84.03M -1.1B -85.01M -83.17M -3.48B | -34.44M -29.64M -27.9M -25.43M -47.57M -3.28B -47.76M -331M -128M -1.67B -129M -127M -5.29B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | $1.015 | -1.46% | 126,387 |
| 26-09-09 | $1.030 | -5.50% | 1,364,316 |
| 26-09-08 | $1.090 | +0.93% | 1,312,122 |
| 26-09-04 | $1.080 | -1.82% | 535,726 |
| 26-09-03 | $1.100 | -0.90% | 917,013 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions

















